The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Good point Zen on the timeline, and something they would have been well aware of last week - so as pointed out, why didn't they just incorporate this release into the previous one ? Producing an RNS after market on a Friday seems a bit spivy. Hopefully the iis with a direct line to the Board will still be on the case come Monday.
It does seem daft taking the effort of issuing an RNS (and paying for it) just to tell the market you're going to be issuing an RNS, and then not release one, so expecting something today. I was always advised that these had to be down the wire for 7am
Be nice to have a success story, but I'd still like to see it back trading. We were suspended back in 2022 pending getting a company changing deal over the line, or not. It's obviously not over the line - and as far as investors are informed we may be even further away. In the meantime there's been practically radio silence on everything. I'm sure noone envisaged a 1yr+ suspension, but how long can this go on if the SS status quo persists ? 2 years/longer ? Certainly they should not be able to roll the suspension onto another deal being worked on, and only come back when they've delivered something as has been suggested.
Tier - I do wonder how long the suspension can continue. There are projects in Africa still awaiting signature five years on. We are getting on for one and a half years. There has to be a drop dead date, and as far as I'm concerned we've past it. It doesn't sound to me like a signature is imminent in spite of what the Co may be convincing LSE, and in Africa small steps forward can be knocked back in a flash with the carousel of changing government personnel who have other ideas. For me this has also added a significant risk factor to SAVE shares if/when they resume trading pending the next potential lengthy suspension, and I'll be looking to reduce my position.
EE. Presumably if still over the 3% threshold they need to still notify and change ? Any idea when any further news likely ? (hard work working O&G farm-outs these days !)
Zen - Your last comment mirrors my views exactly. Why the preoccupation of not coming back without a deal ? If there's not a deal and the share price tanks it will realign when the deal is announced to something close to what it would relist at if there was a deal. Likewise if never any deal. I don't necessarily understand he logic of those not wanting it back trading. I just want some ops updates on existing business, and at the moment it seems they don't feel inclined or obliged to supply this. If there's any further extension, I would assume AIM being taken for a bit of a ride.
SP. Sort of with you on this. I look at energy projects for a living from a commercial perspective with a view to raising finance for them - used to be mainly O&G, but now more renewables. I learnt a while ago to pick my battles. Spent ages of 'free time' looking at projects which had a low chance of securing funding and moving forward - for all sorts of reasons, - Geol risk, Tech level, location, management. Still do the odd high risk/reward but they're rare. I didn't buy into SAVE originally with my punt money, so maybe looking for something others aren't. I hope in a few days I'll be eating my words, but besides Nigeria some of these locations they're putting a lot their eggs into (even if they get sanction) are too scary for me and I'll be taking some money off the table.
Komakino - I'm still surprised that UK listed companies can operate in countries such as Chad and SS given the UK corporate governance rules. I'd just like to see the shares relisted regardless of where we are on SS, so the Board become a bit more accountable and forthcoming. Shame we don't have a stronger Nomad.
Shame that they've made use of the one year suspension period to inform shareholders of virtually nothing, and when they do put out an RNS with a supposed update, it tells us - virtually nothing. Would have been nice to combine with an ops update of what's going on elsewhere. I hope they are not still paying Comarco a quarterly retainer.
Well said Kelboy, but thanks Rocky for trying. I think that's why the suspension has to be lifted as its been a convenient excuse to keep us uninformed about other ops updates - even if there is nothing new on SS. I don't quite understand the reluctance from some to get it trading again. The share price will settle where it settles if SS done or not done. Fed up with seeing a flat line (and limited news updates) to get to that point though.
Good to give the PR guys something to do as they presumably had a fairly cushy ride while the shares are suspended - and the Investor Relations part is virtually cut off. For my part I just want to get the shares trading again. If they tumble on the back on no news so be it, as they'll realign if/when the deal is done/not done - and the company will be more inclined to give operations updates on existing operations which have been scant to say the least.
Any idea who is continuing to feed the market ? You would have thought just by virtue of the reduced number of shares (and market cap staying constant) that the share price would show some slight positive trajectory.
If it is correct, you assume the Co must be aware of such significant movements - and might have reached out and prompted for a TR1 disclosure.
I do wonder legally or ethically how long they can keep rolling on the suspension. It's currently suspended on the basis of a deal that wasn't the reason for the initial suspension, and talk of working on another deal if SS fails, and a another extension to the already extended suspension period does make we wonder if they are playing a bit fast and loose to avoid having the shares trading until they have possibly managed to pull something out of the hat. Can anyone shed any light on what the Nomad might need to support an extension request ?